title: YKL-40 acts as an angiogenic factor to promote tumor angiogenesis.
abstract: A secreted glycoprotein YKL-40 also named chitinase-3-like-1 is normally expressed by multiple cell types such as macrophages, chondrocytes, and vascular smooth muscle cells. However, a prominently high level of YKL-40 was found in a wide spectrum of human diseases including cancers and chronic inflammatory diseases where it was strongly expressed by cancerous cells and infiltrating macrophages. Here, we summarized recent important findings of YKL-40 derived from cancerous cells and smooth muscle cells during tumor angiogenesis and development. YKL-40 is a potent angiogenic factor capable of stimulating tumor vascularization mediated by endothelial cells and maintaining vascular integrity supported by smooth muscle cells. In addition, YKL-40 induces FAK-MAPK signaling and up-regulates VEGF receptor 2 in endothelial cells; but a neutralizing antibody (mAY) against YKL-40 inhibits its angiogenic activity. While YKL-40 is essential for angiogenesis, little is known about its functional role in tumor-associated macrophage (TAM)-mediated tumor development. Therefore, significant efforts are urgently needed to identify pathophysiological function of YKL-40 in the dynamic interaction between tumor cells and TAMs in the tumor microenvironment, which may offer substantial mechanistic insights into tumor angiogenesis and metastasis, and also point to a therapeutic target for treatment of cancers and other diseases.
authors.affiliation: Molecular and Cellular Biology Program, Morrill Science Center, University of Massachusetts Amherst, MA, USA ; Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, MA, USA.
authors.forename: Rong
authors.initials: R
authors.lastname: Shao
keywords: VEGF; YKL-40; angiogenesis; neutralizing anti-YKL-40 antibody; tumor cells; tumor microenvironment; tumor-associated macrophages; vascular endothelial cells